This page in English
Laddar profil information

Om mig

M.D. Ph.D. FEBO

S:t Eriks Ögonsjukhus

Institutionen för klinisk neurovetenskap, Karolinska Institutet

Utbildning

2018. Fellow of the European Board of Ophthalmology (FEBO)

2013-2017. Ph.D. Institutionen för onkologi-patologi, Karolinska Institutet

2005-2011. Läkarprogrammet (M.D.), Uppsala universitet

2007. Patologi, Université Catholique de Lille, Frankrike

Forskningsbeskrivning

  • Ögononkologi och ögonpatologi
  • Prediktiva och prognostiska biomarkörer

Pedagogiska meriter

  • Oftalmologi, Karolinska Institutet
  • Mentorskap för läkarstudenter, Karolinska Institutet
  • Kliniska kurser, S:t Eriks Ögonsjukhus
  • Humananatomi, Uppsala universitet

Akademiska priser och utmärkelser

  • Årets avhandling 2017, Svensk Förening för Patologi: Länk
  • Susan G. Komen AACR Scholar in training award, San Antonio Breast Cancer Symposium 2015
  • Forskningsanslag, S:t Eriks Ögonforskningsstiftelse, Ögonfonden och Karolinska Institutets stiftelsemedel för ögonforskning
  • Wallmarks stipendium "till skicklig behövande yngre akademisk lärare", Uppsala universitet 2010
  • Lincks, Alreiks- och Erasmusstipendium, Uppsala universitet 2007-2010

Dokument

Publikationer

Digital image analysis of Ki67 in hot spots is superior to both manual Ki67 and mitotic counts in breast cancer
Stålhammar G, Robertson S, Wedlund L, Lippert M, Rantalainen M, Bergh J, et al
Histopathology 2018;72(6):974-989

Evolutionary history of metastatic breast cancer reveals minimal seeding from axillary lymph nodes
Ullah I, Karthik Gm, Alkodsi A, Kjällquist U, Stålhammar G, Lövrot J, et al
The Journal of clinical investigation 2018;128(4):1355-1370

Exome sequencing of primary breast cancers with paired metastatic lesions reveals metastasis-enriched mutations in the A-kinase anchoring protein family (AKAPs)
Kjällquist U, Erlandsson R, Tobin Np, Alkodsi A, Ullah I, Stålhammar G, et al
BMC cancer 2018;18(1):174-

Prognostic value of Ki67 analysed by cytology or histology in primary breast cancer
Robertson S, Stålhammar G, Darai-ramqvist E, Rantalainen M, Tobin Np, Bergh J, et al
Journal of clinical pathology 2018;():-

Tumour thickness, diameter, area or volume? The prognostic significance of conventional versus digital image analysis-based size estimation methods in uveal melanoma
Arnljots Ts, Al-sharbaty Z, Lardner E, All-eriksson C, Seregard S, Stålhammar G
Acta ophthalmologica 2018;():-

Intra-tumor heterogeneity in breast cancer has limited impact on transcriptomic-based molecular profiling
Karthik Gm, Rantalainen M, Stalhammar G, Lovrot J, Ullah I, Alkodsi A, et al
BMC CANCER 2017;:802-

Digital image analysis outperforms manual biomarker assessment in breast cancer
Stålhammar G, Fuentes Martinez N, Lippert M, Tobin Np, Mølholm I, Kis L, et al
Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc 2016;29(4):318-29

Gene protein detection platform--a comparison of a new human epidermal growth factor receptor 2 assay with conventional immunohistochemistry and fluorescence in situ hybridization platforms
Stålhammar G, Farrajota P, Olsson A, Silva C, Hartman J, Elmberger G
Annals of diagnostic pathology 2015;19(4):203-10

Response to correspondence on 'low concordance of biomarkers in histopathological and cytological material from breast cancer'
Stålhammar G, Hartman J
Histopathology 2015;66(5):756-8

Low concordance of biomarkers in histopathological and cytological material from breast cancer
Stålhammar G, Rosin G, Fredriksson I, Bergh J, Hartman J
Histopathology 2014;64(7):971-80

Sebaceous epithelial-myoepithelial carcinoma of the parotid gland: a case report of a new histologic variant
Stålhammar G, Elmberger G
Annals of diagnostic pathology 2014;18(4):248-52

Visa alla publikationer

Karta

Presentationer

Videopresentation av Gustav Stålhammar